Part I of Understanding Multiple Myeloma

Paul Richardson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on December 28, 2018 On Part I of a two part episode, Dr. Ken Miller talks with Dr. Paul Richardson, a hematologist/oncologist at Dana-Farber Cancer Center in Boston, MA, as he describes his journey as a clinical investigator and how that journey shaped his perspective when treating patients. Dr. Richardson discusses the biology of the disease, state-of-the-art care, how smoldering myeloma differs from the disease of myeloma, the use of vaccines in cancer treatment, and so much more! Paul Richardson, MD Clinical Program Leader Director of Clinical Research Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute Boston, MA